-
‘I had to grab the bull by the horns,’ says Lucy Wojcik, Chief IP Counsel, on transforming Ocado’s IP team
Read more: ‘I had to grab the bull by the horns,’ says Lucy Wojcik, Chief IP Counsel, on transforming Ocado’s IP teamIn an interview with ip fray during IP Dealmakers Europe last month, Ms. Wojcik discussed transforming Ocado’s non-existent IP team into an eight-strong unit, behind the scenes of the historical AutoStore dispute, which at one point had over 100 counsel working on the cases across six jurisdictions, and C-suite communication.
-
USPTO Director orders PTAB to reconsider invalidity finding for Pictiva patent at center of $191M damages claim against Samsung
Read more: USPTO Director orders PTAB to reconsider invalidity finding for Pictiva patent at center of $191M damages claim against SamsungThe Patent Trial and Appeal Board and an Eastern District of Texas jury came to opposing conclusions about the validity of the PAE’s OLED patent.
-
UK court gives significant weight to Nokia offer in interim-payment ruling against Warner Bros. Discovery, Paramount
Read more: UK court gives significant weight to Nokia offer in interim-payment ruling against Warner Bros. Discovery, ParamountThe High Court of Justice for England & Wales has set confidential interim payments pending a November 2026 RAND trial, giving significant weight to Nokia’s prior lump-sum offer and noting that rejection of the streamers’ valuation model could result in a step change worth tens of millions of dollars.
-
Federal Circuit affirms invalidation of Enanta’s Paxlovid-related patent: finds “typo” defense insufficient to fix written description gap in provisional filing
Read more: Federal Circuit affirms invalidation of Enanta’s Paxlovid-related patent: finds “typo” defense insufficient to fix written description gap in provisional filingThe United States Court of Appeals for the Federal Circuit has affirmed the invalidation of Enanta’s Paxlovid-related patent, rejecting its bid to blame a one-carbon typo in its provisional filing, and leaving Pfizer’s earlier disclosure now free to anticipate the claims.
-
Korean monetization platform behind Pantech SEP campaigns targets Hisense, TCL with display patents from Asian tech companies
Read more: Korean monetization platform behind Pantech SEP campaigns targets Hisense, TCL with display patents from Asian tech companiesFairLight Innovations LLC is suing the two Chinese companies in the Eastern District of Texas.
-
USPTO Director Squires extends 14-day deadline for Director Review of institution decisions to 30 days – or more “in exceptional circumstances”
Read more: USPTO Director Squires extends 14-day deadline for Director Review of institution decisions to 30 days – or more “in exceptional circumstances”He noted that “changed circumstances can surface after the deadline… has elapsed but before trial has progressed meaningfully” and that sua sponte Director Review is “not always the most efficient process”.
-
China’s Supreme People’s Court confirms Innoscience’s China GaN injunctions against Infineon are interim relief
Read more: China’s Supreme People’s Court confirms Innoscience’s China GaN injunctions against Infineon are interim reliefChina’s top court has published its decisions in Innoscience v. Infineon, which support ip fray’s reading of Innoscience’s China GaN win over Infineon as interim relief, not final merits wins.
Follow Us
Latest Articles
- Oura reignites U.S. Ultrahuman patent infringement battle after $2.2B IPO
- Disney disables HEVC on Disney+ in Brazil following Huawei injunction, appeals order
- Skechers fends off most infringement claims but can’t escape UPC Munich injunction over one of four accused shoe models
- UPC grants Yangtze Memory application to intervene in Micron patent suit targeting downstream partners
- Taction seeks supplemental damages, interest, ongoing royalties through 2035 on top of $5.7B Apple verdict